Breaking News Instant updates and real-time market news.

UTX

United Technologies

$127.25

-0.2 (-0.16%)

05:38
11/06/18
11/06
05:38
11/06/18
05:38

Pratt & Whitney APS3200 APU selected by Loong Air for new fleet

Pratt & Whitney Canada, a subsidiary of United Technologies, announced that Loong Air has selected the APS3200 auxiliary power unit, or APU, for the airline's order of 29 firm and 5 option Airbus A320 family aircraft. Pratt & Whitney Canada and Loong Air have also signed a long-term comprehensive support agreement to cover the APS3200 APU maintenance. With this APU selection, Loong Air will operate up to 68 Airbus A320 family aircraft with the APS3200 APU.

UTX United Technologies
$127.25

-0.2 (-0.16%)

08/20/18
RBCM
08/20/18
NO CHANGE
RBCM
United Technologies offered 'plenty' to stay positive, says RBC Capital
RBC Capital analyst Deane Dray writes that in his investor meetings with United Technologies, the company offered "plenty of reason" to stay positive on the stock. Specifically, the analyst cites the management's confidence in concluding the Rockwell Collins acquisition in September as well as the progress in the geared turbofan, or GTF, development. Dray adds that he was also surprised with the management's candid discussions of the pros/cons of a three-way portfolio break-up.
10/17/18
10/17/18
NO CHANGE

UTC Aerospace Systems announces 5-year agreement with Wizz Air
UTC Aerospace Systems, a unit of United Technologies, announced a five-year agreement with Wizz Air to provide thrust reverser overhaul services for the airline's fleet of Airbus A320ceo aircraft. This agreement builds upon the company's history of providing maintenance, overhaul and repair services to carriers around the world.
10/24/18
RBCM
10/24/18
NO CHANGE
Target $148
RBCM
Outperform
United Technologies price target lowered to $148 from $161 at RBC Capital
RBC Capital analyst Deane Dray lowered his price target on United Technologies (UTX) to $148 to reflect his updated model of an anticipated 3-way break-up "dis-synergies" after the completion of its Rockwell Collins (COL) deal, with the Board having indicated its intentions to review the portfolio in 2-6 weeks. The analyst keeps his Outperform rating however after the company's "solid" Q3 beat which offset the "ongoing challenges at Otis" and demonstrated that tariff-related risk is "manageable".
10/25/18
10/25/18
UPGRADE
Target $112

Overweight
Ingersoll-Rand upgraded to Overweight at KeyBanc
As previously reported, KeyBanc analyst Jeffrey Hammond upgraded Ingersoll-Rand (IR) to Overweight from Sector Weight, with a $112 price target, to reflect a more positive view on its premium execution, favorable late-cycle mix, and potential to benefit from a closer look into relative HVAC valuations brought to light by United Technologies' (UTX) likely spin of Carrier. Following the recent pull back, the analyst now views Ingersoll-Rand's valuation as compelling.

TODAY'S FREE FLY STORIES

08:35
11/19/18
11/19
08:35
11/19/18
08:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

FRME

First Merchants

$41.23

0.06 (0.15%)

08:33
11/19/18
11/19
08:33
11/19/18
08:33
Upgrade
First Merchants rating change  »

Sandler ONeill upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$115.51

-1.84 (-1.57%)

08:33
11/19/18
11/19
08:33
11/19/18
08:33
Recommendations
PVH Corp. analyst commentary  »

PVH Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

CLX

Clorox

$162.02

1.51 (0.94%)

08:31
11/19/18
11/19
08:31
11/19/18
08:31
Conference/Events
Clorox management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

08:31
11/19/18
11/19
08:31
11/19/18
08:31
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$101.29

1.56 (1.56%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$64.10

0.62 (0.98%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Conference/Events
Interxion management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FCSC

Fibrocell Science

$2.08

0.015 (0.73%)

, LPNT

LifePoint

$65.00

(0.00%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Options
Five option delistings on November 19th »

Option delistings…

FCSC

Fibrocell Science

$2.08

0.015 (0.73%)

LPNT

LifePoint

$65.00

(0.00%)

NYRT

New York REIT

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHLD

National Holdings Corp

$2.96

(0.00%)

08:30
11/19/18
11/19
08:30
11/19/18
08:30
Hot Stocks
Breaking Hot Stocks news story on National Holdings Corp »

National Holdings Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENDP

Endo

$12.70

-0.035 (-0.27%)

08:29
11/19/18
11/19
08:29
11/19/18
08:29
Conference/Events
Endo management to meet with Cantor Fitzgerald »

Endo holds a Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

SIX

Six Flags

$59.79

1 (1.70%)

08:27
11/19/18
11/19
08:27
11/19/18
08:27
Recommendations
Six Flags analyst commentary  »

Six Flags checks show Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACBI

Atlantic Capital

$17.32

0.04 (0.23%)

08:27
11/19/18
11/19
08:27
11/19/18
08:27
Upgrade
Atlantic Capital rating change  »

Atlantic Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVEE

NV5 Global

$73.44

-0.23 (-0.31%)

08:27
11/19/18
11/19
08:27
11/19/18
08:27
Hot Stocks
NV5 Global awarded $17M location, survey services contract from NCDOT »

NV5 Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNA

Arena Pharmaceuticals

$41.67

2.13 (5.39%)

08:26
11/19/18
11/19
08:26
11/19/18
08:26
Recommendations
Arena Pharmaceuticals analyst commentary  »

Arena Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MATW

Matthews

$43.21

2.91 (7.22%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Recommendations
Matthews analyst commentary  »

Matthews price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
HSBC to hold a conference »

China Healthcare…

QURE

uniQure

$31.89

0.89 (2.87%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
uniQure to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CFX

Colfax

$28.00

0.31 (1.12%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
Colfax to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

UMRX

Unum Therapeutics

$8.07

0.1 (1.25%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
Unum Therapeutics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 01

    Dec

ADIL

Adial Pharmaceuticals

$1.28

-0.05 (-3.76%)

08:24
11/19/18
11/19
08:24
11/19/18
08:24
Hot Stocks
Adial Pharmaceuticals engages Crown CRO to begin Phase 3 trial for AD04 »

Adial Pharmaceuticals and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:23
11/19/18
11/19
08:23
11/19/18
08:23
Conference/Events
Daiwa to hold a conference »

Asia Communication Days…

VICI

VICI Properties

$21.29

0.16 (0.76%)

08:22
11/19/18
11/19
08:22
11/19/18
08:22
Initiation
VICI Properties initiated  »

VICI Properties initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.